INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "PHARMACEUTICAL DOSAGE FORMS COMPRISING 2-(2-CHLOROPHENYL)-N-[4-(4-CYANO-1H-PYRAZOL-1-YL)-3-SULFAMOYLPHENYL]ACETAMIDE"

GENEVA, March 17 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2024/074820) for "PHARMACEUTICAL DOSAGE FORMS COMPRISING 2-(2-CHLOROPHENYL)-N-[4-(4-CYANO-1H-PYRAZOL-1-YL)-3-SULFAMOYLPHENYL]ACETAMIDE" on Sep 05, 2024. With publication no. WO/2025/051851, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUESSENBACH, Yasmin Isabelle (BorchemstraBe 1240597 Dusseldorf), MERKEL, Susanne (LilienstraBe 19e42719 Solingen), FREUNDLIEB, Julia (Heidkopf 2444229 Dortmund), MUNSTER...